Solid Tumors, Adult

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

Imaging of Solid Tumors Using FAP-2286

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

A Study of GC203 TIL in Advanced Solid Tumors (NF)

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors

NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors

Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy

PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors

Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors

Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours

Study of ON 123300 in Patients With Advanced Cancer

Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors